8 employees
CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.
2021
$1.7M
from 4 investors over 4 rounds
CardiaTec Biosciences LTD raised $1.7M on July 6, 2022
Investors: o2h ventures, Cambridge Enterprise, Crista Galli Ventures and Laidlaw Scholars Ventures